Woodman Primary Care LLC

Woodman Primary Care LLC was paid $222K by Medicaid between Feb 2019 and Aug 2022, across 27 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 25% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	13,529	$96K
2020	8,274	$69K
2021	353	$34K
2022	222	$23K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	25%	557	431	$56K
80347		5.7%	908	548	$13K
80364		5.1%	908	548	$11K
80361		4.9%	908	548	$11K
83992		4.0%	907	548	$9K
80359		2.8%	908	548	$6K
80336		2.8%	908	548	$6K
80349		2.8%	908	548	$6K
80358		2.8%	908	548	$6K
80354		2.8%	908	548	$6K
80348		2.8%	908	548	$6K
80356		2.8%	908	548	$6K

15 more codes

80365		2.8%	908	$6K
80372		2.7%	907	$6K
80373		2.7%	907	$6K
80370		2.7%	907	$6K
80353		2.7%	907	$6K
80360		2.7%	908	$6K
80345		2.7%	907	$6K
80368		2.7%	907	$6K
80326		2.7%	908	$6K
80355		2.7%	908	$6K
80366		2.7%	907	$6K
80323		2.5%	859	$6K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.2%	129	$5K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	16	$2K
81003		<1%	849	$304.68

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKOLACZKOWSKI, JEFFREY (DIRECTOR)

Same official

Other billing entities under KOLACZKOWSKI, JEFFREY

Full network →

Provider	Location	Paid
Communikare Behavioral Health Services LLC	Dayton, OH	$2.16M
Woodman Primary Care LLC	Dayton, OH	$716K
Communikare Behavioral Health Services LLC	Dayton, OH	$593K
Wellness Card LLC	Dayton, OH	$438K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.